<?xml version="1.0" encoding="UTF-8"?>
<p>All serum samples were screened for exposure to RVFV using RVFV specific IgM and IgG enzyme-linked immunosorbent assays (ELISA). The commercial kits used were manufactured by Biological Diagnostic Supplies Limited (BDSL), Scotland, UK, and used according to the manufacturer protocols and published procedures. These kits were originally developed by the Special Pathogens Unit of the National Institute for Communicable Diseases (SPUNICD), Sandringham, South Africa [
 <xref rid="pntd.0007979.ref037" ref-type="bibr">37</xref>]. The sensitivity and specificity to the standard panel of positive and negative samples was indicated as 100% respectively. Briefly, all serum samples were diluted 1:20 and heat inactivated at 56Â°C for 30 minutes and then the IgM and IgG ELISA were conducted per manufacturer instructions. The plates were analyzed at 405nm.
</p>
